SomnoMed (SomnoMed) Accounts Payable & Accrued Expense : $7.57 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Accounts Payable & Accrued Expense?

SomnoMed's quarterly accounts payable & accrued expense increased from Dec. 2022 ($7.89 Mil) to Jun. 2023 ($8.21 Mil) but then declined from Jun. 2023 ($8.21 Mil) to Dec. 2023 ($7.57 Mil).

SomnoMed's annual accounts payable & accrued expense increased from Jun. 2021 ($8.10 Mil) to Jun. 2022 ($9.03 Mil) but then declined from Jun. 2022 ($9.03 Mil) to Jun. 2023 ($8.21 Mil).

SomnoMed Accounts Payable & Accrued Expense Historical Data

The historical data trend for SomnoMed's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Accounts Payable & Accrued Expense Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5.63

5.91

8.10

9.03

8.21

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															8.61	9.03	7.89	8.21	7.57

SomnoMed Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

SomnoMed (SomnoMed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

RJV:Germany SOM:Australia

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (SomnoMed) Headlines

From GuruFocus

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire • 10-28-2022

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire • 07-26-2022